{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 168,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       ":Compilation_Completed"
      ]
     },
     "execution_count": 168,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Important improvements:\n",
    "#    Improve trial success statistical basis\n",
    "#    Replace htxthresh with some sort of probabalistic sampling\n",
    "#    Base p23 n on p1-based power calculation (https://clincalc.com/stats/samplesize.aspx)\n",
    "#    At present, a pt can be treated with many drugs, including any number of drugs for the very same varient!\n",
    "#       This leads to over-the-top improvments, although it's not entirely obvious that this isn't\n",
    "#       a perfectly plausible strategy (cf. the 9-component GBM treatment), esp. before particular\n",
    "#       precision treatments haven't been approved. There are several things we're ignoring, specifically\n",
    "#       combined toxicity and drug interactions.\n",
    "#  Minor issues:\n",
    "#    There's a bug where because of the order of ops, the pts can end up with health << 0 just before death\n",
    "#    Allow \"cures\" (at present you only accrue variants, never lose them!) Maybe when healh == 1.0, clear varvac?\n",
    "#    There's some sort of bug where the trial is transitioned/closed multiple times.\n",
    "#  Possible Improvements:\n",
    "#    Treatments should have a bimodal structure, like variants\n",
    "#    Model decision making agents -- hypers go with d.m. agents\n",
    "#    Maybe txs should stop having an effect; possibly bcs the disease mutates away from the target variant\n",
    "#       to a new biomarker configuration. At present this makes no difference bcs we are assuming that we\n",
    "#       test on every cycle and treat to the results of the test (i.e., we \"chase\" the biomarkers).\n",
    "#       But more correctly we would treat with the same drug until it stops working.\n",
    "\n",
    "using Random\n",
    "using Distributions\n",
    "using Printf\n",
    "#using CPUTime\n",
    "using PyPlot; const plt = PyPlot\n",
    "\n",
    "global gloglevel = 0\n",
    "log!(msg,lvl=0) = lvl >= gloglevel ? print(msg) : false\n",
    "\n",
    "##########################################################################################\n",
    "# Globals and Hyperparmaters:\n",
    "##########################################################################################\n",
    "\n",
    "# Values declared as hypers are stored in the ghyps dictionary. This makes it convenient to\n",
    "# save them with run results, but makes access very slow, so use lets to pull them into local around\n",
    "# inner loops. Each entry in the dict is a pair: [current_value, default_value]. In initialization\n",
    "# we call sethyps() to set the current values to either defaiults, or to user-given values.\n",
    "\n",
    "# ******************************************************************************\n",
    "# *** WARNING: Computed hyperparams need to be computed and set in sethyps() ***\n",
    "# *** Any settings here of computed hyper paremeters are placeholders to     ***\n",
    "# *** show the sort of thing that these hyps are.                            ***\n",
    "# ******************************************************************************\n",
    "\n",
    "global ghyps = Dict()\n",
    "\n",
    "macro hyp(variable, value); ghyps[:($variable)] = [eval(:($value)),eval(:($value))]; end\n",
    "macro hyp(variable); :(ghyps[($variable)][1]); end # You have to use :symbols to make this work\n",
    "showhyps() = for (hyp, cd) in ghyps; @printf(\"%s=%s (default=%s)\\n\", hyp, cd[1], cd[2]) ; end\n",
    "\n",
    "##########################################################################################\n",
    "# General Hypers\n",
    "##########################################################################################\n",
    "\n",
    "@hyp npts 30\n",
    "@hyp nvars 10 # n variants describing a patient\n",
    "@hyp nyears 50\n",
    "\n",
    "# Turning this off will circumvent the trial process and go straight to expanded access.\n",
    "@hyp trialsp true\n",
    "\n",
    "# (Note that ending a name in \"p\" is a Lisp convention that indicates\n",
    "#  a predicate, that is, a function that does a test, and returns a\n",
    "#  boolean (true/false) or a t/f variable. Since Julia idiotically\n",
    "#  doesn't allow the more natural ? to be used, as: \"trials?)\n",
    "\n",
    "##########################################################################################\n",
    "# Treatment-Related Hypers\n",
    "##########################################################################################\n",
    "\n",
    "# Only treat when you get below this level (FFF This should have measurement error!)\n",
    "@hyp treatment_threshold 0.7\n",
    "\n",
    "# Hypers for positive and negative treatment effect sizes:\n",
    "@hyp tx_effect_size_mean_for_positive_variant 0.5 # Effect Size Mean of the postively-targed variant\n",
    "@hyp tx_effect_size_dev_for_positive_variant 0.1\n",
    "@hyp tx_effect_size_mean_for_negative_variant -0.1\n",
    "@hyp tx_effect_size_dev_for_negative_variant  0.1\n",
    "\n",
    "##########################################################################################\n",
    "# Incidnence and Effect Size of Variants\n",
    "##########################################################################################\n",
    "\n",
    "# Variant occurrance dist (when sampled N>0.5)\n",
    "# Simplified Beta Hyper Parameters [alpha,beta]\n",
    "@hyp simplified_beta_parameters Dict(:farleftpeak => [1.5,20], :leftpeak => [3,11], :centered => [10,10], :rightpeak => [11,3])\n",
    "\n",
    "# Get a mean and deviation (usually for normal sampling) centered at the keyed beta, and with the keyed deviation\n",
    "Beta_Based_Mean_and_Dev(key) = rand(Beta(@hyp(:simplified_beta_parameters)[key][1],@hyp(:simplified_beta_parameters)[key][2]))\n",
    "\n",
    "@hyp variant_occurrence_dists [Normal(0.0,0.001) for i in 1:@hyp(:nvars)] # Just placeholders -- will get set at init time\n",
    "\n",
    "@hyp variant_mixture_model_1_mean 0.05\n",
    "@hyp variant_mixture_model_1_dev 0.01\n",
    "@hyp variant_mixture_model_2_mean 0.20\n",
    "@hyp variant_mixture_model_2_dev 0.10\n",
    "\n",
    "# Because these have to add to 1.0, we compute variant_mixture_model2w in sethyps(), that way you only have to change variant_mixture_model_1_w\n",
    "# to change the mixture. We only need variant_mixture_model2w here to set the default for vesds\n",
    "@hyp variant_mixture_model_1_weight 0.95\n",
    "@hyp variant_mixture_model_2_weight 1-@hyp(:variant_mixture_model_1_weight)\n",
    "\n",
    "@hyp variant_mixture_model_effects_dev 0.1 # Deviation for N effect sizes centered on mixture model samples (FFF??? Sample this too?)\n",
    "\n",
    "# Variant effect size distributions (vesds) is sampled from a bimodal mixture. NOTE: The effect size here is a\n",
    "# \"hit\", that is, the values here are the NEGATIVE effect of a variant. The bimodality is trying to model most\n",
    "# variants having a small negative effect, and rare variants having a large negative effect.\n",
    "\n",
    "@hyp variant_mixture_model MixtureModel(Normal[Normal(0.0, 0.001),Normal(0.1, 0.001)],[0.5,0.5]) # Recomputed in init using variant_mixture_model... hypers\n",
    "@hyp variant_effect_size_dists [Normal(rand(@hyp(:variant_mixture_model)),@hyp(:variant_mixture_model_effects_dev)) for i in 1:@hyp(:nvars)] # Recomputed in init\n",
    "\n",
    "function print_variant_effect_size_dists()\n",
    "    log!(\"Variant effect size distributions:\\n\")\n",
    "    for dist in @hyp(:variant_effect_size_dists)\n",
    "        log!(@sprintf(\"%s\\n\",dist))\n",
    "    end\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Structs, Global stores, Creators, and Printers\n",
    "##########################################################################################\n",
    "\n",
    "# Pateints are described by binary variant vectors, beginning at [0,...,0] and collecting variants at\n",
    "# the rate given by the variant occurrance probability (vop, per year==cycle). Each variant\n",
    "# also has an effect size (ves), which actually the mean and sd of the gaussian effect size, again, per year.\n",
    "# So, as patients develop variants over time, their health, which begins at 1.0, starts declining in accord\n",
    "# with collected variants. The trial could concienvably be a multie-tx field, but at the moment off-trial\n",
    "# treatments are one-shot and dependent on immediate variant tests, so we don't need to record txs other\n",
    "# than trials. The trial will be false if there's no trial.\n",
    "\n",
    "mutable struct pt; id; health; variant_vector; history; trial; trial_cycles end\n",
    "global gpts = []\n",
    "ptfmt(pt) = @sprintf(\"{Pt#%2d=%.2f%s{%s}}\",pt.id,pt.health,pt.variant_vector,ctfmt(pt.trial))\n",
    "mean_survival(pts)=mean(map(pt->((last(pt.history)!=0.0) ? @hyp(:nyears) : (findall(h->h==0.0,pt.history)[1])),pts))\n",
    "pts_with_variant(vn;pts=gpts) = filter(pt->pt.variant_vector[vn]==1,pts)\n",
    "\n",
    "# A treatment (tx) is just the target variant (by index), an set of effect size distributions (normals),\n",
    "# and an approval status, which is either true, for an approved tx, false for a failed on, or\n",
    "# a clinical trial structure. We create a new targted tx is based on when the number of patients\n",
    "# to die with a particular variant reaches > some % of the population.\n",
    "# The status will either be a trial, or true if it's approved\n",
    "# Effect model (em): [[variant number, effect distribution]...]\n",
    "\n",
    "mutable struct tx; id; effect_model; status; end\n",
    "global gtxs = []\n",
    "\n",
    "effect_modelfmt(effect_model) = string(map(m->@sprintf(\"[%s,N%s]\",m[1],params(m[2])),effect_model))\n",
    "txfmt(tx) = @sprintf(\"<Tx#%2d(%s):%s>\",tx.id,ctshortfmt(tx.status),effect_modelfmt(tx.effect_model))\n",
    "\n",
    "# Give the indeces of the status=non-false teatments for a given variant.\n",
    "live_treatment_indexes_for_variant(vn) = findall(tx->tx.status!=false&&vn==tx.effect_model[1][1],gtxs)\n",
    "\n",
    "# Clinical trials go trough 2 phases: 1 and 2/3 (23). The first phase seeks to power the second phase. When a new\n",
    "# drug is invented, it goes into a phase 1 trials, and can NOT be used except in the trial. Once it\n",
    "# passes phase 1 (if it does), it goes into a specifically-powered phase 23 trial. At THAT point, anyone\n",
    "# can use the drug. Patients who are enrolled in either a phase 1 or phase 2 trial only get the trial\n",
    "# treatment, whereas patients who are NOT in a trial can get any drug that is in phase 2 or beyond.\n",
    "# So an advantage of going into a phase 1 trials is that you get drug before anyone else. The disadvantage\n",
    "# is that you're stuck with that one drug. One question is, why would anyone who could get the drug anyway,\n",
    "# bother going into a phase 2/3 trial? The answer is that they wouldn't, but that's not the world we live in.\n",
    "# So there is another factor, which is that any patient who CAN go into a trial MUST go into a trial (under the\n",
    "# :strict policy). In :strict there is a health cutoff for the trial, which is based on the phase 1 analysis.\n",
    "# Any patient with the target mutation who passes the health cutoff MUST (under :strict) go into the 23 trial.\n",
    "# The :strict policy is actually more like the real world, and it's probably the comparison case. The other\n",
    "# policy (:open), any can get any drug that has passes phase 1, and so there's no reason that anyone would\n",
    "# go into a phase 23 trial, when they can just get tested all the time, and get whatever drug they want, and\n",
    "# any number of them, and change all the time. In fact, :open is to obviously better than :strict, and so not-\n",
    "# the-way-the-world-really-is, that I haven't even bother to implement :open!\n",
    "\n",
    "@hyp phase1_ptsneeded 3 # This looks like it shouldn't be a constant, but in practice, it actually is!\n",
    "@hyp phase1_duration_per_patient 3 # FFF ??? Maybe go to dose escalation, or patient response\n",
    "@hyp phase23_ptsneeded 3 # FFF Compute from Phase 1 results, see: https://clincalc.com/stats/samplesize.aspx\n",
    "@hyp phase23_duration_per_patient 3 # FFF Ditto should be computed based on phase 1, although less critical than n\n",
    "mutable struct ct; id; txs; pts; phase; ptsneeded; duration_per_patient; end\n",
    "\n",
    "global all_trials = []\n",
    "global phase23_trials = []\n",
    "global completed_trials = []\n",
    "global failed_trials = []\n",
    "\n",
    "ctfmt(ct) = @sprintf(\"[CT%2dph%d,n=%s]\",ct.id,ct.phase,length(ct.pts))\n",
    "ctfmt(status::Bool) = status\n",
    "ctshortfmt(status::Bool) = status\n",
    "ctshortfmt(ct) = @sprintf(\"[CT%2dp%d]\",ct.id,ct.phase)\n",
    "\n",
    "# Compute the effectiveness of a treatment on a trial, i.e., the ratio of mean survival on the trial vs. off\n",
    "# The \"off\" pts are those with the target vatiant, but were NOT on the trial. ??? How are we treating right censoring ???\n",
    "\n",
    "function trial_result(trial)\n",
    "   let offpts = setdiff(pts_with_variant(trial.txs[1].effect_model[1][1]),trial.pts)\n",
    "      (trial.pts == [] || offpts == []) ? :uncomputable : mean_survival(trial.pts)/mean_survival(offpts)\n",
    "   end\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Variants (biomarkers)\n",
    "##########################################################################################\n",
    "\n",
    "# Variants are accrued randomly throughout life.\n",
    "\n",
    "# Variant occurs? predicate (i.e., > 0.5) => true/false\n",
    "variant_occursp(vn) = (rand(@hyp(:variant_occurrence_dists)[vn]) > 0.5)\n",
    "\n",
    "# Maybe gain a variant (nvars just passed in for efficiency so we don't have to @hyp it)\n",
    "gain_variants(variant_vector,nvars) = [((variant_occursp(vn) > 0.5) ? 1 : variant_vector[vn]) for vn in 1:nvars]\n",
    "\n",
    "# Patient health hit is the amount to reduce the pt's health based on the sum of samples\n",
    "# from all of the accrued variants.\n",
    "\n",
    "function variant_based_health_hit(variant_vector)\n",
    "    let variant_effect_size_dists = @hyp(:variant_effect_size_dists)\n",
    "        reduce(+,[variant_vector[vn]*rand(variant_effect_size_dists[vn]) for vn in 1:@hyp(:nvars)])\n",
    "    end\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Treating and creating new treatments\n",
    "##########################################################################################\n",
    "\n",
    "# The parameters that create new treatments and trials interact complexly:\n",
    "# When the number of patients in a given diagnosis (i.e., a given vn) exceeds tx_invention_death_fraction*total population,\n",
    "# there's the possibility of creating a new treatment. Once that level is passed, then a normal draw has to come above\n",
    "# new_tx_creation_threshold in order for the treatment to actually be created. (FFF These could be rolled together.)\n",
    "# Every new treatment gets a new phase 1 trial. txs_per_variant_limit is a hard limit on the number of treatments either\n",
    "# appraoved, or in trials (that is, whose status is not false) for a given diagnosis (vn) (FFF Make this probabalistic.)\n",
    "\n",
    "@hyp tx_invention_death_fraction 0.1\n",
    "@hyp new_tx_creation_threshold 0.8\n",
    "@hyp killed_threshold_for_new_tx_creation NaN # Gets init'ed in init() [Needs to be same type to avoid conv errs]\n",
    "@hyp txs_per_variant_limit 1\n",
    "\n",
    "# Each time a new treatment is created, it is intially created in the context of a clinical trial,\n",
    "# and as long as there is a trial for that treatment available, that's the preferred way to be treated.\n",
    "# In a phase 1 trials, it's the ONLY way you can get treated, but once the trial is in phase 2/3 (23)\n",
    "# anyone who is not in the trial's target model (meaning doesn't have the excluded variants), can get\n",
    "# the treatment, but patients in the trial MUST stay on the trial regimen, whereas others can get the tx\n",
    "# but aren't required to follow protocol if they end up not doing so well on the drug.\n",
    "\n",
    "function maybe_create_a_new_tx() # maybe create a new treatment\n",
    "    # For each of the places where the counts of pts killed by particular variants > kill threshold\n",
    "    # decide whether to create a tx, and create it. (Note that there can be more than one tx/variant!)\n",
    "    let killed_threshold_for_new_tx_creation = @hyp(:killed_threshold_for_new_tx_creation),\n",
    "          new_tx_creation_threshold = @hyp(:new_tx_creation_threshold),\n",
    "          txs_per_variant_limit = @hyp(:txs_per_variant_limit)\n",
    "        killedpts = map(pt->pt.variant_vector,filter(pt->pt.health==0,gpts))\n",
    "        killedpts != [] ? killedpts = reduce(+,killedpts) : []\n",
    "        log!(@sprintf(\"Patient kill per variant counts: %s (killed_threshold_for_new_tx_creation=%s,new_tx_creation_threshold=%s)\\n\",killedpts, killed_threshold_for_new_tx_creation,new_tx_creation_threshold))\n",
    "        for vn in (killedpts != [] ? findall(x->x>killed_threshold_for_new_tx_creation,killedpts) : [])\n",
    "            # Has to be above the newtx threshold, and can't exceed the number of txs for this var already created\n",
    "            if rand(Normal())>new_tx_creation_threshold && length(live_treatment_indexes_for_variant(vn))<=txs_per_variant_limit\n",
    "                new_tx(vn)\n",
    "            end\n",
    "        end\n",
    "    end\n",
    "end\n",
    "\n",
    "# Although each new tx is targeted to a particular variant, we also create side-effect\n",
    "# variant effects with a certain (small) probability. These are generally slightly negative,\n",
    "# whereas\n",
    "\n",
    "function new_tx(vn)  # FFF Rationalize the effect size, and add a clinical trial in the status\n",
    "    # First is the main effect (generally +) and one side effect (-centered) FFF Makes these more flexible\n",
    "    # (Also, the main effect and side effect could cancel if they are the same vn -- prob disallow this! FFF UUU)\n",
    "    # Under one FFF theory, there should be a small side effect for EVERY vn -- too complex, maybe some day)\n",
    "    # A new tx gets a phase 1 trial for just this treatment. FFF trials can be started for multiple\n",
    "    # treatments through a different channel.\n",
    "    ntx=tx(1+length(gtxs),\n",
    "           [[vn,Normal(@hyp(:tx_effect_size_mean_for_positive_variant),@hyp(:tx_effect_size_dev_for_positive_variant))],\n",
    "            [rand(1:@hyp(:nvars)),Normal(@hyp(:tx_effect_size_mean_for_negative_variant),@hyp(:tx_effect_size_dev_for_negative_variant))]], \n",
    "           true) # Start out approved, and if you're going to run trials, this will get replaced with a phase 1 trial\n",
    "    if @hyp(:trialsp)\n",
    "        nct = ct(1+length(all_trials),[ntx],[],1,@hyp(:phase1_ptsneeded),@hyp(:phase1_duration_per_patient))\n",
    "        ntx.status=nct\n",
    "        push!(all_trials,nct)\n",
    "    end\n",
    "\n",
    "    push!(gtxs,ntx)\n",
    "    log!(@sprintf(\"Creating new tx: %s\\n\",txfmt(ntx)))\n",
    "end\n",
    "\n",
    "# When you treat a patient, you treat every variant for which he has a positive test\n",
    "# (tests are assumed to be correct! FFF: Probabalize tests!) If there are several possible\n",
    "# approved treatments for a a given variant, you choose one uniformly at random.\n",
    "\n",
    "function treat(pt)\n",
    "    # If the patient is on a trial, the treatment is determined by the trial,\n",
    "    # otherwise, you can treat per variants\n",
    "    ct = pt.trial\n",
    "    if ct == false\n",
    "        find_trial_or_freetreat(pt)\n",
    "    else\n",
    "        # Treat with the trail treatment, and then update the trial stats\n",
    "        log!(@sprintf(\"Treating pt#%s on trial %s\\n\",pt.id,ct.id))\n",
    "        treatwith(pt,ct.txs[1])\n",
    "        # If the pt has been on the trial the required number of cycles, take them off\n",
    "        if ct.duration_per_patient == pt.trial_cycles\n",
    "            log!(@sprintf(\"Taking pt#%s off trial %s\\n\",pt.id,ct.id))\n",
    "            # Nb. Taking a patient off a trial removes the trial from the patient record, but does not\n",
    "            # remove the patient from the TRIAL's record. We always remember which patients we treated on the trial\n",
    "            pt.trial = false\n",
    "            # Consider closing this trial if this is the last patient, and it's not already closed\n",
    "            # Patients can still be on the trial even though it's technically closed.\n",
    "            # No new ones can be recruited, but ones already on can be recruited.\n",
    "            if (length(ct.pts)==ct.ptsneeded)\n",
    "                # If the trial failed, shut down the treatment\n",
    "                let result = trial_result(ct)\n",
    "                    #println(string(\"***************\",result))\n",
    "                    if  (result == :uncomputable || result < 1.0) # ??? uncomputeable trials are assumed to have failed\n",
    "                        log!(@sprintf(\"Trial %s FAILED! Killing TX#%s!\\n\",ct.id,ct.txs[1].id))\n",
    "                        ct.txs[1].status = false\n",
    "                        push!(failed_trials,ct)\n",
    "                    else\n",
    "                        # Close the trial successfully: convert p1 to p23, approve drugs on p23 success\n",
    "                        if ct.phase == 1\n",
    "                            log!(@sprintf(\"Converting trial %s from phase 1 to phase 23\\n\",ct.id))\n",
    "                            push!(phase23_trials,ct)\n",
    "                            ct.phase = 23\n",
    "                            ct.ptsneeded = @hyp(:phase23_ptsneeded)\n",
    "                            # FFF !!! Compute from phase 1 variance: https://clincalc.com/stats/samplesize.aspx\n",
    "                            ct.duration_per_patient == @hyp(:phase23_duration_per_patient)\n",
    "                        else\n",
    "                            log!(@sprintf(\"Trial %s has been completed, approving %s!\\n\",ct.id, ct.txs[1].id))\n",
    "                            push!(completed_trials,ct)\n",
    "                            ct.txs[1].status = true # Mark this treatment as approved!\n",
    "                        end\n",
    "                    end\n",
    "                end\n",
    "            end\n",
    "        else\n",
    "            pt.trial_cycles = pt.trial_cycles + 1\n",
    "        end\n",
    "    end\n",
    "end\n",
    "\n",
    "function find_trial_or_freetreat(pt)\n",
    "    # The number of patients needed for a trial is used to decide whether a trial is available\n",
    "    # When phase 1 is done, the ptsneeeded will be reset to the appropriate number for p23, and will\n",
    "    # again count up. Once the p23 trial is completed, the ptsneeded will be full up, and won't get\n",
    "    # reset, so the trial will never be selected again.\n",
    "    goodtrials = filter(ct->(applicabletxp(ct.txs[1],pt.variant_vector)&&(length(ct.pts)<ct.ptsneeded)),all_trials)\n",
    "    if goodtrials != []\n",
    "        ct = rand(goodtrials)\n",
    "        pt.trial = ct\n",
    "        pt.trial_cycles = 1\n",
    "        ct.pts=cat(ct.pts,pt,dims=1)\n",
    "        log!(@sprintf(\"Enrolled pt%s in trial %s\\n\",pt.id,ct.id))\n",
    "        treat(pt)\n",
    "    else\n",
    "        log!(@sprintf(\"Free Treating pt#%s\\n\",pt.id))\n",
    "        freetreat(pt)\n",
    "    end\n",
    "end\n",
    "\n",
    "function applicabletxp(tx,variant_vector)\n",
    "    # The first elt of the vn array is the target\n",
    "    1==variant_vector[(map(vn_ves->vn_ves[1],tx.effect_model))[1]]\n",
    "end\n",
    "\n",
    "# If we find a trial that this patient can go on, we do that, otherwise, we treat all the variants they have\n",
    "# The treatment either has to have no attached trials, or anh attached trial must be in phase23. The reason we\n",
    "# might get here even though there are trials for this vn, is that the available trials might be full up.\n",
    "\n",
    "function freetreat(pt)\n",
    "    for vn in findall(v->v==1,pt.variant_vector)\n",
    "        # Find all possible treatments for this variant:\n",
    "        # And then keep only those that aren't in a trial, or are in phase 23\n",
    "        txs = filter(tx->(tx.status!=false)&&((tx.status==true)||(tx.status.phase==23)),filter(tx->[]!=findall(vn_ves->vn_ves[1]==vn,tx.effect_model),gtxs))\n",
    "        txs != [] ? treatwith(pt,txs[rand(1:end)]) : log!(@sprintf(\"No available treatments!\\n\"))\n",
    "    end\n",
    "end\n",
    "\n",
    "\n",
    "# Treating a patient entails applying an effect size (es) sample from each of the applicable\n",
    "# effect models in the tx. Each em is a pair of a variant number and an effect distribution for that\n",
    "# variant. Even though the variants are chosen to target one particular vn, all the vns that this pt\n",
    "# has will be applied! This models side effects.\n",
    "\n",
    "function treatwith(pt,tx)\n",
    "    log!(@sprintf(\"Treating pt#%s (%.2f) with %s\\n\",pt.id,pt.health,txfmt(tx)))\n",
    "    for (vn,ves) in tx.effect_model\n",
    "        pt.variant_vector[vn]==1 ? pt.health=pt.health+rand(ves) : false # If this is a side effect, the dist will be negatively biased\n",
    "    end\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Drivers\n",
    "##########################################################################################\n",
    "\n",
    "function init(loglevel,overrides)\n",
    "    # Clear collectors\n",
    "    global gloglevel=loglevel\n",
    "    global gpts = [pt(p, 1.0, [0 for i in 1:@hyp(:nvars)], [1.0], false, nothing) for p in 1:@hyp(:npts)] # not on any trials to begin with\n",
    "    global gtxs = []\n",
    "    global all_trials = []\n",
    "    global phase23_trials = []\n",
    "    global failed_trials = []\n",
    "    global completed_trials = []\n",
    "    sethyps(overrides)\n",
    "end\n",
    "\n",
    "function sethyps(overrides) # overrides is, e.g.: [:foo, 5.2], which will override the default\n",
    "    for (hyp, cd) in ghyps; cd[1]=cd[2]; end # First set everything to default\n",
    "    for (hyp, newval) in overrides; ghyps[hyp][1]=newval; end # Now override anything requested\n",
    "    # *********************************************************************************************\n",
    "    # Now we have to compute computed hypers -- WWW Note that you can't override computed hypers\n",
    "    # bcs they get recomputed here! (Prob. should test for this and barf!)\n",
    "    ghyps[:killed_threshold_for_new_tx_creation][1]=@hyp(:npts)*@hyp(:tx_invention_death_fraction)\n",
    "    # Recompute variant effect bimodal mixture\n",
    "    ghyps[:variant_mixture_model_2_weight][1]=1.0-@hyp(:variant_mixture_model_1_weight)\n",
    "    ghyps[:variant_mixture_model][1]=\n",
    "         MixtureModel(Normal[Normal(@hyp(:variant_mixture_model_1_mean), @hyp(:variant_mixture_model_1_dev)),\n",
    "                             Normal(@hyp(:variant_mixture_model_2_mean),@hyp(:variant_mixture_model_2_dev))],\n",
    "                     [@hyp(:variant_mixture_model_1_weight),@hyp(:variant_mixture_model_2_weight)])\n",
    "    ghyps[:variant_effect_size_dists][1]=[Normal(rand(@hyp(:variant_mixture_model)),@hyp(:variant_mixture_model_effects_dev)) for i in 1:@hyp(:nvars)]\n",
    "    ghyps[:variant_occurrence_dists][1]=[Normal(Beta_Based_Mean_and_Dev(:farleftpeak,:centered),\n",
    "                                                Beta_Based_Mean_and_Dev(:leftpeak,:centered)) for i in 1:@hyp(:nvars)]\n",
    "\n",
    "    # *********************************************************************************************\n",
    "    gloglevel <= 5 ? showhyps() : []\n",
    "end\n",
    "\n",
    "seevariant_mixture_model()=plt.hist(rand(@hyp(:variant_mixture_model),1000),100)\n",
    "\n",
    "# Test shows lots of logging whereas run shows none, and averages the average mortalities over all runs.\n",
    "# You can override any hyperparameter on either with overrides=[[:hyp,newval],...]\n",
    "# ** Note that overrides, if you use them, have to be a list of lists, as: overrides=[[:foo,10],[:bar,20]]\n",
    "\n",
    "function test(;overrides=[],loglevel=0) # Watch as variants accrue and health declines\n",
    "    init(loglevel,overrides)\n",
    "    log!(print_variant_effect_size_dists())\n",
    "    let nyears = @hyp(:nyears), treatment_threshold = @hyp(:treatment_threshold), nvars = @hyp(:nvars)\n",
    "        for year in 1:nyears\n",
    "            log!(@sprintf(\"\\n-------- %s --------\\n\",year))\n",
    "            for pt in gpts\n",
    "                # There's a sort of which-comes-first problem here about changing health level, then zero'ing it out\n",
    "                # if it's under 0, and then treating or not. Probably this logic could be simplified a bit FFF ???\n",
    "                pt.variant_vector=gain_variants(pt.variant_vector,nvars)\n",
    "                (pt.health > 0) ? (pt.health=pt.health-variant_based_health_hit(pt.variant_vector)) : false # Not sure why this syntax requires an else (:) ???\n",
    "                # (FFF Probably do this with tanh instead of these hard limits?)\n",
    "                (pt.health <= 0) ? (pt.health = 0) : (pt.health < treatment_threshold ? treat(pt) : false)\n",
    "                (pt.health >= 1.0) ? (pt.health = 1.0) : false\n",
    "                push!(pt.history,pt.health)\n",
    "            end\n",
    "            maybe_create_a_new_tx()\n",
    "        end\n",
    "        if loglevel == 0\n",
    "            plt.plot([[[pt.history for pt in gpts][i][j] for i in 1:ghyps[:npts][1]] for j in 1:nyears]) # UUU Array rotation\n",
    "            #plt.text(nyears-20,-0.2,\"maybe add a label?\")\n",
    "            plt.ylabel(\"Health\")\n",
    "            plt.xlabel(\"Years from Diagnosis\")\n",
    "            println(\"\\n\\nTrial results:\\n\")\n",
    "            map(x->println(x),[trial_result(all_trials[i]) for i in 1:length(all_trials)])\n",
    "            for (obs,fmtfn) in ((gpts, ptfmt),(gtxs,txfmt),(all_trials,ctfmt)); map(ob->@printf(\"%s\\n\",fmtfn(ob)),obs); end\n",
    "            @printf(\"\\nTotal trials: %s, Completed trials: %s, Failed trials: %s\\n\",\n",
    "                    length(all_trials), length(completed_trials), length(failed_trials))\n",
    "            println(\"\\nHyper paramters:\\n\"); show(ghyps)\n",
    "        end\n",
    "        return Dict(:mean_survival=>mean_survival(gpts),\n",
    "                    :n_all_trials=>length(all_trials),\n",
    "                    :n_completed_trials=>length(completed_trials),\n",
    "                    :n_failed_trials=>length(failed_trials),\n",
    "                    :n_phase23_trials=>length(phase23_trials)\n",
    "                    )\n",
    "    end\n",
    "end\n",
    "\n",
    "run(;n=10,overrides=[])=[test(loglevel=99,overrides=overrides) for i in 1:n]\n",
    "\n",
    "# Scan a single hyp value\n",
    "function run(overkey::Symbol,from::Real,to::Real,step::Real;result_key=:mean_survival,n=10,otheroverrides=[])\n",
    "    local all_results = []\n",
    "    let overrider = [[overkey,NaN]]\n",
    "        for val in from:step:to\n",
    "            overrider[1][2]=val\n",
    "            # Each run will give you a single number per run, we collect them and then do the mean and std of these\n",
    "            results = map(r->r[result_key],run(n=n,overrides=vcat(overrider,otheroverrides)))\n",
    "            push!(all_results,[val,results])\n",
    "        end\n",
    "    end\n",
    "    let x=[x[1] for x in all_results], y=[mean(x[2]) for x in all_results]\n",
    "        plt.scatter(x,y)\n",
    "        plt.plot(x,y)\n",
    "        plt.errorbar(x, y, yerr=[(std(x[2])/sqrt(n)) for x in all_results])\n",
    "        plt.ylabel(result_key)\n",
    "        plt.xlabel(string(overkey))\n",
    "    end\n",
    "    :Done\n",
    "end\n",
    "\n",
    ":Compilation_Completed\n",
    "\n",
    "# Basic tests:\n",
    "#test()\n",
    "#run(;n=10,overrides=[])=[test(loglevel=99,overrides=overrides) for i in 1:n]\n",
    "#test(overrides=[[:tx_effect_size_mean_for_positive_variant,-1.5]])\n",
    "#run(:tx_invention_death_fraction,0.0,1.0,0.1,n=20)\n",
    "#run(:treatment_threshold,0.0,1.0,0.1,n=20)\n",
    "#run(:treatment_threshold,0.0,1.0,0.1,n=20,otheroverrides=[[:trialsp,false]])\n",
    "#run(:tx_effect_size_mean_for_positive_variant,0.5,-0.5,-0.1,n=20,otheroverrides=[[:trialsp,true]])\n",
    "#run(:treatment_threshold,0.0,1.0,0.1,n=20,otheroverrides=[[:trialsp,false]])\n",
    "#run(:treatment_threshold,0.0,1.0,0.1,n=20,otheroverrides=[[:trialsp,true]])\n",
    "\n",
    "# Scanning the size of treatment effect primary mode\n",
    "#run(:tx_effect_size_mean_for_positive_variant,0.5,-0.5,-0.1,n=20,otheroverrides=[[:trialsp,true]])\n",
    "#run(:tx_effect_size_mean_for_positive_variant,0.5,-0.5,-0.1,n=20,otheroverrides=[[:trialsp,false]])\n",
    "#run(:variant_mixture_model_1_weight,0.5,0.95,0.1,n=20) # Scanning the mixture weights of tx effectiveness -- seems to make no difference! ???\n",
    "\n",
    "# Experiments scanning the size and duration of trials:\n",
    "#run(:phase23_duration_per_patient,3,33,5,n=20)\n",
    "#run(:phase23_ptsneeded,3,33,5,n=20)\n",
    "#run(:phase1_ptsneeded,3,33,2,n=100,result_key=:mean_survival,otheroverrides=[[:tx_effect_size_mean_for_positive_variant,-1.0]])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 167,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "Figure(PyObject <Figure size 640x480 with 1 Axes>)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       ":Done"
      ]
     },
     "execution_count": 167,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "run(:tx_effect_size_mean_for_positive_variant,-0.5,1.5,0.25,n=200)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "run(:tx_effect_size_mean_for_positive_variant,-0.5,1.5,0.25,n=200)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Julia 1.5.2",
   "language": "julia",
   "name": "julia-1.5"
  },
  "language_info": {
   "file_extension": ".jl",
   "mimetype": "application/julia",
   "name": "julia",
   "version": "1.5.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
